Clinic-pathological aspect of gastro-intestinal stromal tumors at tertiary care Hospital India

Autor: P Suresh, Amamndeep Sing Sandhu, Sankar Subramanian, Jagan Balu

Publikováno v: Journal of Coloproctology (Rio de Janeiro) v.40 n.1 2020
Journal of Coloproctology (Rio de Janeiro. Online)
Sociedade Brasileira de Coloproctologia (SBCP)
instacron:SBCP
Journal of Coloproctology, Vol 40, Iss 1, Pp 12-19 (2020)
Journal of Coloproctology (Rio de Janeiro), Volume: 40, Issue: 1, Pages: 12-19, Published: 23 MAR 2020

Background: This study defines the disease profile in south Indian population and determine the clinic-pathological aspects of Gastro-Intestinal Stromal Tumors. Method: In this prospective study patients diagnosed of gastrointestinal stromal tumors w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b2f609699f0651968df0672bb39bce5
https://doi.org/10.1016/j.jcol.2019.09.006

Insights into ligand stimulation effects on gastro-intestinal stromal tumors signalling

Autor: Karthik Arumugam, Nathalie Nicot, Elisabeth Letellier, Christelle Bahlawane, Serge Haan, Petr V. Nazarov, Martine Schmitz

Publikováno v: Cell Signal. (2017).

Mutations in KIT or PDGFRA are responsible for >85% of gastrointestinal stromal tumors. The introduction of imatinib in the GIST therapy scheme revolutionized the patient outcome. Unfortunately, the therapy allows the disease stabilization instead of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b9de1a505212f720ad001b684de7657

Etude fonctionnelle des formes oncogéniques de KIT : nouvelles stratégies d'inactivation de la signalisation oncogénique KIT

Autor: Le Gall, Marianne

Lorsqu’il est surexprimé ou activé constitutivement par mutation, le récepteur tyrosine kinase KIT est impliqué dans le développement de pathologies prolifératives comme les mastocytoses, les tumeurs stromales gastro-intestinales (GIST) et ce

Externí odkaz: http://www.theses.fr/2014PA11T017/document

Three cases of bone metastases in patients with gastrointestinal stromal tumors

Autor: Laura Greco, Alberto Bazzocchi, Anna Mandrioli, Cristian Lolli, Garzillo Giorgio, Maurizio Zompatori, Alessandra Maleddu, Monica Di Battista, Valerio Di Scioscio, Guido Biasco, Maristella Saponara, Maria Caterina Pallotti, Margherita Nannini, Maria Abbondanza Pantaleo

Publikováno v: Rare Tumors
Scopus-Elsevier
Rare Tumors, Vol 3, Iss 2, Pp e17-e17 (2011)

Gastrointestinal stromal tumors (GISTs) are rare, but represent the most common mesenchymal neoplasms of the gastrointestinal tract. Tumor resection is the treatment of choice for localized disease. Tyrosine kinase inhibitors (imatinib, sunitinib) ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e791d22fff2e5f2f7892b6ed4f99c1fc
http://europepmc.org/articles/PMC3132121

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.